Dynamic changes of MELD scores can predict the prognosis of HBV-related acute-on-chronic liver failure

Xiao-hui LIU,Ming LI,Hai-qing GUO,Ya-li CHEN,Jin-qiu HE,Shu-qin ZHANG,Wen-fang WU,Zhong-ping DUAN,Jing ZHANG

2014-01-01

Abstract:Objective To determine whether the dynamic changes of the model for end-stage liver disease (MELD) scores were superior to baseline MELD scores in predicting the prognosis of HBV-related acute-on-chronic liver failure (HBV-ACLF). Methods A prospective study was made on HBV-ACLF patients hospitalized in four hospitals in China from 2009 to 2011. The clinical data including clinical manifestations, laboratory findings and the prognosis were observed, and the relationship between the dynamic changes of MELD scores and the prognosis was analyzed. Results The 90-day mortality rate of the enrolled 82 HBV-ACLF patients was 37.80%. The average baseline MELD scores in the non-survivor group and the survivor group were 25.50±4.77 and 23.72± 4.68, respectively, and the difference between the two groups was not significant (P=0.101). The MELD scores gradually increased in the non-survivor group, and decreased in the survivor group from the 7th day of enrollment. The differences were significant between the two groups at the following time-points. MELD scores of the survivors were significantly less than those of the non-survivors in the low-risk group (with the baseline MELD scores less than or equal to 23) from the 14th day of enrollment (16.04±4.00 vs 29.39± 12.30, P<0.05), and MELD scores of the survivors were significantly less than those of the non-survivors in the high-risk group (with the baseline MELD scores more than 23) from the 7th day of enrollment (22.38±4.91 vs 28.92±6.76, P=0.001). The variations became greater as time went on. Conclusion Dynamic changes of MELD scores should be considered additionally in predicting the prognosis of HBV-ACLF besides baseline MELD scores, which will help improve the accuracy of predicting the prognosis.